Therefore, the observed deregulation of the Ras/RAF/MAPK signaling pathway in GBM is attributed to its upstream positive regulators, including EGFR and PDGFR, which are highly active in the majority of malignant gliomas [87,151]. Here, PDGFRB is linked to glioblastoma.